The rebound was fueled by Windtree Therapeutics' commitment to invest $520 million in BNB for its corporate treasury.

BNB/USDhits a fresh all-time high on positive developments. It hits a high of $855 and is currently trading around $851.50.

Biotech firm Windtree plans $520M Binance Coin bet via stock deals and credit line, pending shareholder approval amid mixed ...

Windtree Therapeutics, recently made waves by announcing plans to allocate up to $700 million toward acquiring BNB.

BNB (BNB), formerly known as Binance Coin, edges lower after hitting a new all-time high of $855 at press time on Monday. The ...

Nasdaq-listed Windtree Therapeutics will raise $520 million through an equity line of credit and a stock purchase agreement, ...

Windtree said it aims to become the first NASDAQ-listed company to offer direct exposure to BNB. The treasury strategy ...

Nasdaq-listed biotech company Windtree Therapeutics (WINT) announced it has signed a $500 million equity line of credit (ELOC ...

Windtree Therapeutics (WINT), a Nasdaq listed biotechnology company, plans to raise up to $200 million to build a treasury of ...

Windtree Therapeutics' latest move goes beyond its surprising forays into real estate and waste management, as the company ...

Windtree Therapeutics has entered agreements to raise up to $520 million for BNB cryptocurrency acquisition, with a total commitment nearing $700 million. The company plans to direct 99% of funds ...

Windtree Therapeutics secures $520M to pivot into a BNB-focused crypto treasury strategy, marking a bold move for corporate ...